MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
Agenus Depreciation & Amortization 2011-2025 | AGEN
Annual Depreciation & Amortization Agenus
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.6 M | 6.95 M | 6.79 M | 7.18 M | 6.66 M | 6.29 M | 6.01 M | 4.95 M | 1.96 M | 1.58 M | 586 K | 1.62 M | 2.25 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.6 M | 586 K | 5.11 M |
Quarterly Depreciation & Amortization Agenus
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 3.2 M | - | - | - | 3.37 M | - | - | - | 2.56 M | - | 5.06 M | 3.35 M | 1.66 M | - | 5.13 M | 3.45 M | 1.73 M | - | 5.34 M | 3.49 M | 1.7 M | - | 5 M | 3.32 M | 1.64 M | - | 4.74 M | 3.11 M | 1.56 M | - | 4.56 M | 3.06 M | 1.53 M | - | 3.66 M | 2.52 M | 1.24 M | - | 1.4 M | 885 K | 445 K | - | 1.02 M | 589 K | 267 K | - | 448 K | 312 K | 147 K | - | 1.49 M | 1.09 M | 550 K | - | 1.7 M | 1.13 M | 567 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.34 M | 147 K | 2.26 M |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Autolus Therapeutics plc
AUTL
|
7.55 M | $ 1.87 | 11.68 % | $ 477 M |  Britain |
 |
Aclaris Therapeutics
ACRS
|
807 K | $ 3.0 | -0.99 % | $ 232 M |  USA |
 |
Alpine Immune Sciences
ALPN
|
597 K | - | - | $ 2.17 B | USA |
 |
Aptorum Group Limited
APM
|
1.13 M | $ 1.1 | -3.51 % | $ 6 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | USA |
 |
AlloVir
ALVR
|
398 K | - | 4.14 % | $ 49.1 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | USA |
 |
BioVie
BIVI
|
229 K | $ 1.22 | 0.83 % | $ 1.8 M | USA |
 |
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | USA |
 |
AVROBIO
AVRO
|
617 K | - | 1083.1 % | $ 745 M | USA |
 |
BioDelivery Sciences International
BDSI
|
140 K | - | -4.8 % | $ 255 M | USA |
 |
Athersys
ATHX
|
1.43 M | - | 3.77 % | $ 22.4 M | USA |
 |
ARCA biopharma
ABIO
|
27 K | - | 1052.0 % | $ 415 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
11 K | - | -9.72 % | $ 5.89 M | USA |
 |
Acasti Pharma
ACST
|
7 K | - | 4.01 % | $ 150 M |  Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
9.45 M | - | -15.15 % | $ 60.3 M | Britain |
 |
Can-Fite BioPharma Ltd.
CANF
|
14 K | $ 0.17 | -18.84 % | $ 370 M |  Israel |
 |
Berkeley Lights
BLI
|
9 M | - | -7.31 % | $ 87 M | USA |
 |
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | USA |
 |
Catalyst Biosciences
CBIO
|
1.07 M | $ 12.12 | -1.86 % | $ 798 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
28.2 M | $ 26.86 | -0.96 % | $ 1.3 B | USA |
 |
BeiGene, Ltd.
BGNE
|
172 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Calithera Biosciences
CALA
|
300 K | - | -10.95 % | $ 876 K | USA |
 |
Anika Therapeutics
ANIK
|
6.43 M | $ 9.53 | -0.21 % | $ 140 M | USA |
 |
Certara
CERT
|
1.99 M | $ 8.85 | -0.45 % | $ 1.42 B | USA |
 |
bluebird bio
BLUE
|
28 M | - | - | $ 546 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
3.87 M | - | -6.81 % | $ 3.04 B | USA |
 |
Acer Therapeutics
ACER
|
66 K | - | 2.71 % | $ 14 M | USA |
 |
Axon Enterprise
AXON
|
48.4 M | $ 583.1 | -0.13 % | $ 44.2 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
5.38 M | $ 2.55 | 4.08 % | $ 16 M | USA |
 |
ChromaDex Corporation
CDXC
|
663 K | - | -0.88 % | $ 598 M | USA |
 |
Acorda Therapeutics
ACOR
|
31.7 M | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
41 K | - | -5.38 % | $ 6.06 M | USA |
 |
Celldex Therapeutics
CLDX
|
3.18 M | $ 25.93 | -1.8 % | $ 1.67 M | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
24.9 M | $ 11.43 | 2.65 % | $ 739 M | USA |